• Poster

An Exploration of the Association of QOL Scores With Tumor Progression Status in First-Line HR+, HER2+ MBC Patients Treated With Lapatinib Plus Letrozole or Letrozole Alone

Citation

Sherrill, B., Amonkar, M., Sherif, B., Maltzman, J., O'Rourke, L., & Johnston, S. (2009, December). An Exploration of the Association of QOL Scores With Tumor Progression Status in First-Line HR+, HER2+ MBC Patients Treated With Lapatinib Plus Letrozole or Letrozole Alone. Presented at 32nd San Antoniio Breast Cancer Symposium Annual Meeting, .

Abstract